Nanotechnology in Medical Applications: The Global Market
Report Scope:
This report examines the current and forecast market potential for nanomedicine. It offers a detailed analysis of the market background, technological advancements, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for nanomedicine based on therapeutic areas and geography.
By therapeutic area, the nanomedicine market is segmented into anticancer, CNS products, anti-infectives, anti-inflammatories, cardiovascular, and others. By geography, the nanomedicine market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the Word (ROW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are included in the regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on nanomedicine companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
This report examines the current and forecast market potential for nanomedicine. It offers a detailed analysis of the market background, technological advancements, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for nanomedicine based on therapeutic areas and geography.
By therapeutic area, the nanomedicine market is segmented into anticancer, CNS products, anti-infectives, anti-inflammatories, cardiovascular, and others. By geography, the nanomedicine market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the Word (ROW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are included in the regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on nanomedicine companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 24 tables
- An overview of the global markets for nanotechnology used in medical applications
- Estimation of the market size, and analyses of the global market trends with data from 2019, 2020, 2021, with projection of CAGR through 2026
- A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
- Information on significant products in which the nano dimension has made a significant contribution to product effectiveness
- A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
- Identification of key market dynamics, trends, opportunities, and factors influencing the global market and highlights of the market potential for nanotechnology used in medical applications based on type, application, and region
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players in the market, including Abbott, Abraxis Bioscience, Elan, Orthovita Inc., EyePoint Pharmaceuticals Inc. and Farfield Scientific Ltd.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Highlights of the Market for Nanomedicine
CHAPTER 3 MARKET OVERVIEW
Definition
Applications
Drug Delivery
Drugs and Therapy
In Vivo Imaging
In Vitro Diagnostics
Biomaterials
Active Implants
Overview
Medical Nanotechnology: Nanomedicine
Nanotechnology
Nanotechnology Uses
Medical Applications
Environmental Applications
Military Applications
Cosmetics
Nanotechnology Tools
Risks of Nanotechnology
Nanotechnology in the Marketplace
Development of Nanomedical Technologies
Liposomes
Dendrimers
Nanocrystals
Micelles
Fullerenes
Polymeric Nanoparticles
Nanoparticle-Drug Conjugates
Ligand-Targeted Nanoparticles
Ceramic Nanoparticles
Virosome Nanoparticles
Therapeutic Uses of Nanomedicine
Cancer Diagnostics and Therapy
Drug Delivery
Future Trends and Research Possibilities
Non-Invasive Nanodevices
Extracellular Devices
Intracellular Devices
Nanomachines to Control Tissue Healing
Eliminating Viruses
Correcting Chemistry
New Organs and Limbs
Fundamental Nanotechnology Research
U.S.
Europe
Japan
Risk Factors
CHAPTER 4 IMPACT OF COVID-19 PANDEMIC
Introduction
Outbreak
Impact of COVID-19 on Nanomedicine
CHAPTER 5 MARKETS FOR NANOMEDICINE
Market Drivers
Market Estimates and Forecasts
Global Nanomedicine Market
Main Product Categories
Market Analysis by Clinical Application
CHAPTER 6 GLOBAL NANOMEDICINE MARKET BREAKDOWN BY REGION
Introduction
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World (RoW)
CHAPTER 7 COMPETITIVE LANDSCAPE
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches and Partnerships
CHAPTER 8 COMPANY PROFILES
ABBOTT
ABRAXIS BIOSCIENCE (CELGENE {BRISTOL MYERS SQUIBB})
APHIOS CORP.
BIOFORCE NANOSCIENCES HOLDINGS INC.
C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
ELAN (ALKERMES)
EYEPOINT PHARMACEUTICALS INC. (FORMERLY PSIVIDA LTD.)
FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
KLEINDIEK NANOTECHNIK GMBH
LIPLASOME PHARMA APS
MAGFORCE NANOTECHNOLOGIES
MICROFLUIDICS CORP.
NANOBIO CORP. (BLUEWILLOW BIOLOGICS)
NANOBIOTIX SA
NANOCARRIER CO. LTD.
NANOCOPOEIA, LLC.
NANOLOGIX INC.
NANOMIX INC.
NANOSPECTRA BIOSCIENCES INC.
NANOSTRUCTURES INC.
ORTHOVITA INC. (STRYKER CORP.)
PFIZER INC.
SANOFI S.A.
STARPHARMA
TECANGROUP LTD.
TRANSGENEX NANOBIOTECH INC.
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Highlights of the Market for Nanomedicine
CHAPTER 3 MARKET OVERVIEW
Definition
Applications
Drug Delivery
Drugs and Therapy
In Vivo Imaging
In Vitro Diagnostics
Biomaterials
Active Implants
Overview
Medical Nanotechnology: Nanomedicine
Nanotechnology
Nanotechnology Uses
Medical Applications
Environmental Applications
Military Applications
Cosmetics
Nanotechnology Tools
Risks of Nanotechnology
Nanotechnology in the Marketplace
Development of Nanomedical Technologies
Liposomes
Dendrimers
Nanocrystals
Micelles
Fullerenes
Polymeric Nanoparticles
Nanoparticle-Drug Conjugates
Ligand-Targeted Nanoparticles
Ceramic Nanoparticles
Virosome Nanoparticles
Therapeutic Uses of Nanomedicine
Cancer Diagnostics and Therapy
Drug Delivery
Future Trends and Research Possibilities
Non-Invasive Nanodevices
Extracellular Devices
Intracellular Devices
Nanomachines to Control Tissue Healing
Eliminating Viruses
Correcting Chemistry
New Organs and Limbs
Fundamental Nanotechnology Research
U.S.
Europe
Japan
Risk Factors
CHAPTER 4 IMPACT OF COVID-19 PANDEMIC
Introduction
Outbreak
Impact of COVID-19 on Nanomedicine
CHAPTER 5 MARKETS FOR NANOMEDICINE
Market Drivers
Market Estimates and Forecasts
Global Nanomedicine Market
Main Product Categories
Market Analysis by Clinical Application
CHAPTER 6 GLOBAL NANOMEDICINE MARKET BREAKDOWN BY REGION
Introduction
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World (RoW)
CHAPTER 7 COMPETITIVE LANDSCAPE
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches and Partnerships
CHAPTER 8 COMPANY PROFILES
ABBOTT
ABRAXIS BIOSCIENCE (CELGENE {BRISTOL MYERS SQUIBB})
APHIOS CORP.
BIOFORCE NANOSCIENCES HOLDINGS INC.
C SIXTY INC. (ARROWHEAD PHARMACEUTICALS)
ELAN (ALKERMES)
EYEPOINT PHARMACEUTICALS INC. (FORMERLY PSIVIDA LTD.)
FARFIELD SCIENTIFIC (BIOLIN SCIENTIFIC AB)
KLEINDIEK NANOTECHNIK GMBH
LIPLASOME PHARMA APS
MAGFORCE NANOTECHNOLOGIES
MICROFLUIDICS CORP.
NANOBIO CORP. (BLUEWILLOW BIOLOGICS)
NANOBIOTIX SA
NANOCARRIER CO. LTD.
NANOCOPOEIA, LLC.
NANOLOGIX INC.
NANOMIX INC.
NANOSPECTRA BIOSCIENCES INC.
NANOSTRUCTURES INC.
ORTHOVITA INC. (STRYKER CORP.)
PFIZER INC.
SANOFI S.A.
STARPHARMA
TECANGROUP LTD.
TRANSGENEX NANOBIOTECH INC.
LIST OF TABLES
Summary Table A: Global Market for Nanomedicine, by Type, Through 2026
Summary Table B: Global Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 1: Nanomedicine Timescale
Table 2: Main Nanotechnologies Used in Medicine, with Applications
Table 3: Marketed Liposome Nanopharmaceuticals
Table 4: Nanocrystal Pharmaceuticals
Table 5: Marketed and Developmental Products in Micelle Form
Table 6: Marketed Products with Nano-Enhanced Delivery
Table 7: European Nanocenters
Table 8: Marketed Nanopharmaceuticals
Table 9: Global Nanomedicine Market, by Type, Through 2026
Table 10: Global Nanopharmaceuticals Market, by Therapeutic Area, Through 2026
Table 11: Major Marketed Anticancer Nanopharmaceuticals
Table 12: Major Marketed CNS Nanopharmaceuticals
Table 13: Major Marketed Anti-Infective Nanopharmaceuticals
Table 14: Major Marketed Nanomedicines for Cardiovascular and Inflammatory Diseases
Table 15: Global Market for Nanomedicine, by Region, Through 2026
Table 16: North American Market for Nanomedicine, by Type, Through 2026
Table 17: North American Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 18: European Market for Nanomedicine, by Type, Through 2026
Table 19: European Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 20: Asia-Pacific Market for Nanomedicine, by Type, Through 2026
Table 21: Asia-Pacific Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 22: RoW Market for Nanomedicine, by Type, Through 2026
Table 23: RoW Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 24: Global Nanomedicine Market Ranking, by Company, 2020
Summary Table A: Global Market for Nanomedicine, by Type, Through 2026
Summary Table B: Global Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 1: Nanomedicine Timescale
Table 2: Main Nanotechnologies Used in Medicine, with Applications
Table 3: Marketed Liposome Nanopharmaceuticals
Table 4: Nanocrystal Pharmaceuticals
Table 5: Marketed and Developmental Products in Micelle Form
Table 6: Marketed Products with Nano-Enhanced Delivery
Table 7: European Nanocenters
Table 8: Marketed Nanopharmaceuticals
Table 9: Global Nanomedicine Market, by Type, Through 2026
Table 10: Global Nanopharmaceuticals Market, by Therapeutic Area, Through 2026
Table 11: Major Marketed Anticancer Nanopharmaceuticals
Table 12: Major Marketed CNS Nanopharmaceuticals
Table 13: Major Marketed Anti-Infective Nanopharmaceuticals
Table 14: Major Marketed Nanomedicines for Cardiovascular and Inflammatory Diseases
Table 15: Global Market for Nanomedicine, by Region, Through 2026
Table 16: North American Market for Nanomedicine, by Type, Through 2026
Table 17: North American Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 18: European Market for Nanomedicine, by Type, Through 2026
Table 19: European Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 20: Asia-Pacific Market for Nanomedicine, by Type, Through 2026
Table 21: Asia-Pacific Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 22: RoW Market for Nanomedicine, by Type, Through 2026
Table 23: RoW Market for Nanopharmaceuticals, by Therapeutic Area, Through 2026
Table 24: Global Nanomedicine Market Ranking, by Company, 2020
LIST OF FIGURES
Summary Figure A: Global Market for Nanomedicine, by Type, 2019-2026
Summary Figure B: Global Market for Nanopharmaceuticals, by Therapeutic Area, 2019-2026
Figure 1: Global Market Share for Nanomedicine, by Region, 2020
Figure 2: Abbott: Annual Revenue, 2018-2020
Figure 3: Abbott: Revenue Share, by Country, 2020
Figure 4: Abbott: Revenue Share, by Business Segment, 2020
Figure 5: Bristol Myers Squibb: Annual Revenue, 2018-2020
Figure 6: Bristol Myers Squibb: Revenue Share, by Region, 2020
Figure 7: Alkermes: Annual Revenue, 2018-2020
Figure 8: Stryker Corp.: Annual Revenue, 2018-2020
Figure 9: Stryker Corp.: Revenue Share, by Region, 2020
Figure 10: Stryker Corp.: Revenue Share, by Business Segment, 2020
Summary Figure A: Global Market for Nanomedicine, by Type, 2019-2026
Summary Figure B: Global Market for Nanopharmaceuticals, by Therapeutic Area, 2019-2026
Figure 1: Global Market Share for Nanomedicine, by Region, 2020
Figure 2: Abbott: Annual Revenue, 2018-2020
Figure 3: Abbott: Revenue Share, by Country, 2020
Figure 4: Abbott: Revenue Share, by Business Segment, 2020
Figure 5: Bristol Myers Squibb: Annual Revenue, 2018-2020
Figure 6: Bristol Myers Squibb: Revenue Share, by Region, 2020
Figure 7: Alkermes: Annual Revenue, 2018-2020
Figure 8: Stryker Corp.: Annual Revenue, 2018-2020
Figure 9: Stryker Corp.: Revenue Share, by Region, 2020
Figure 10: Stryker Corp.: Revenue Share, by Business Segment, 2020
